Clinical Trials List
Protocol NumberPK NDA-T375-1201
Not yet recruiting
2012-04-01 - 2012-04-30
Phase I
Terminated1
-
Trial Applicant
Orient PHARMA Co., Ltd.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
12 participants
